BioAge Labs (BIOA) Accumulated Depreciation (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Accumulated Depreciation data on file, last reported at $543000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation rose 33.09% year-over-year to $543000.0; the trailing twelve-month figure through Mar 2026 stood at $543000.0 (up 33.09% YoY), and the FY2025 full-year result was $482000.0, up 29.92% from the prior year.
• Accumulated Depreciation grew to $543000.0 in Q1 2026, from $482000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $543000.0 in Q1 2026 to a low of $371000.0 in Q4 2024.
• A 4-year average of $454750.0 and a median of $440500.0 in 2023 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation declined 23.52% in 2025 and surged 33.09% in 2026, its largest moves.
• Tracing BIOA's Accumulated Depreciation over 4 years: stood at $419000.0 in 2023, then slipped by 11.46% to $371000.0 in 2024, then advanced by 29.92% to $482000.0 in 2025, then gained by 12.66% to $543000.0 in 2026.
• Business Quant data shows BIOA's Accumulated Depreciation at $543000.0 in Q1 2026, $482000.0 in Q4 2025, and $413000.0 in Q3 2025.